Differences in FKBP51 Regulation Following Chronic Social Defeat Stress Correlate with Individual Stress Sensitivity: Influence of Paroxetine Treatment

Overview

Journal Neuropsychopharmacology

Date 2012 Aug 9

PMID 22871917

Citations 33

Authors

Klaus V Wagner

Daria Marinescu

Jakob Hartmann

Xiao-Dong Wang

Christiana Labermaier

Sebastian H Scharf

Claudia Liebl

Manfred Uhr

Florian Holsboer

Marianne B Muller

Mathias V Schmidt

Affiliations

Soon will be listed here.

Abstract

Various clinical studies have identified FK506-binding protein 51 (FKBP51) as a target gene involved in the development of psychiatric disorders such as depression. Furthermore, FKBP51 has been shown to affect glucocorticoid receptor signaling by sensitivity modulation and it is implicated in stress reactivity as well as in molecular mechanisms of stress vulnerability and resilience. We investigated the physiological, behavioral, and neuroendocrine parameters in an established chronic stress model both directly after stress and after a recovery period of 3 weeks and also studied the efficacy of paroxetine in this model. We then examined FKBP51 mRNA levels in the dorsal and ventral part of the hippocampus and correlated the expression to behavioral and endocrine parameters. We show robust chronic stress effects in physiological, behavioral, and neuroendocrine parameters, which were only slightly affected by paroxetine treatment. On the contrary, paroxetine led to a disruption of the neuroendocrine system. FKBP51 expression was significantly increased directly after the stress period and correlated with behavioral and neuroendocrine parameters. Taken together, we were able to further elucidate the role of FKBP51 in the mechanisms of stress resilience and vulnerability, especially with respect to behavioral and neuroendocrine parameters. These findings strongly support the concept of FKBP51 as a marker for glucocorticoid receptor sensitivity and its involvement in the development of psychiatric disorders.

Citing Articles

Early-life obesogenic environment integrates immunometabolic and epigenetic signatures governing neuroinflammation.

Ontiveros-Angel P, Vega-Torres J, Simon T, Williams V, Inostroza-Nives Y, Alvarado-Crespo N Brain Behav Immun Health. 2024; 42():100879.

PMID: 39430879 PMC: 11490928. DOI: 10.1016/j.bbih.2024.100879.

Effects of antidepressant on FKBP51 mRNA expression and neuroendocrine hormones in patients with panic disorder.

Zou Z, Huang Y, Maes M, Wang J, He Y, Min W BMC Psychiatry. 2024; 24(1):269.

PMID: 38600448 PMC: 11005249. DOI: 10.1186/s12888-024-05704-4.

Automatically annotated motion tracking identifies a distinct social behavioral profile following chronic social defeat stress.

Bordes J, Miranda L, Reinhardt M, Narayan S, Hartmann J, Newman E Nat Commun. 2023; 14(1):4319.

PMID: 37463994 PMC: 10354203. DOI: 10.1038/s41467-023-40040-3.

Social defeat drives hyperexcitation of the piriform cortex to induce learning and memory impairment but not mood-related disorders in mice.

Wang H, Li F, Zheng X, Meng L, Chen M, Hui Y Transl Psychiatry. 2022; 12(1):380.

PMID: 36088395 PMC: 9464232. DOI: 10.1038/s41398-022-02151-1.

Hippocampal volume, FKBP5 genetic risk alleles, and childhood trauma interact to increase vulnerability to chronic multisite musculoskeletal pain.

Lobo J, Ayoub L, Moayedi M, Linnstaedt S Sci Rep. 2022; 12(1):6511.

PMID: 35444168 PMC: 9021300. DOI: 10.1038/s41598-022-10411-9.

References

Carvalho L, Pariante C . In vitro modulation of the glucocorticoid receptor by antidepressants. Stress. 2008; 11(6):411-24. DOI: 10.1080/10253890701850759. View

Reul J, Stec I, Soder M, Holsboer F . Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology. 1993; 133(1):312-20. DOI: 10.1210/endo.133.1.8391426. View

Hartmann J, Wagner K, Liebl C, Scharf S, Wang X, Wolf M . The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology. 2011; 62(1):332-9. DOI: 10.1016/j.neuropharm.2011.07.041. View

Blokland A, Ten Oever S, van Gorp D, van Draanen M, Schmidt T, Nguyen E . The use of a test battery assessing affective behavior in rats: order effects. Behav Brain Res. 2011; 228(1):16-21. DOI: 10.1016/j.bbr.2011.11.042. View

Berton O, Nestler E . New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006; 7(2):137-51. DOI: 10.1038/nrn1846. View

Sillaber I, Panhuysen M, Henniger M, Ohl F, Kuhne C, Putz B . Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology (Berl). 2008; 200(4):557-72. DOI: 10.1007/s00213-008-1232-6. View

Binder E, Salyakina D, Lichtner P, Wochnik G, Ising M, Putz B . Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004; 36(12):1319-25. DOI: 10.1038/ng1479. View

Sarapas C, Cai G, Bierer L, Golier J, Galea S, Ising M . Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis Markers. 2011; 30(2-3):101-10. PMC: 3825240. DOI: 10.3233/DMA-2011-0764. View

Venzala E, Garcia-Garcia A, Elizalde N, Delagrange P, Tordera R . Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors. Psychopharmacology (Berl). 2012; 224(2):313-25. DOI: 10.1007/s00213-012-2754-5. View

10.

Ulrich-Lai Y, Herman J . Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009; 10(6):397-409. PMC: 4240627. DOI: 10.1038/nrn2647. View

11.

Berton O, McClung C, DiLeone R, Krishnan V, Renthal W, Russo S . Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006; 311(5762):864-8. DOI: 10.1126/science.1120972. View

12.

Krishnan V, Nestler E . The molecular neurobiology of depression. Nature. 2008; 455(7215):894-902. PMC: 2721780. DOI: 10.1038/nature07455. View

13.

Scharf S, Liebl C, Binder E, Schmidt M, Muller M . Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One. 2011; 6(2):e16883. PMC: 3036725. DOI: 10.1371/journal.pone.0016883. View

14.

Bartolomucci A, Palanza P, Sacerdote P, Panerai A, Sgoifo A, Dantzer R . Social factors and individual vulnerability to chronic stress exposure. Neurosci Biobehav Rev. 2005; 29(1):67-81. DOI: 10.1016/j.neubiorev.2004.06.009. View

15.

Pariante C, Miller A . Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry. 2001; 49(5):391-404. DOI: 10.1016/s0006-3223(00)01088-x. View

16.

Ising M, Depping A, Siebertz A, Lucae S, Unschuld P, Kloiber S . Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci. 2008; 28(2):389-98. DOI: 10.1111/j.1460-9568.2008.06332.x. View

17.

Petit-Demouliere B, Chenu F, Bourin M . Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl). 2004; 177(3):245-55. DOI: 10.1007/s00213-004-2048-7. View

18.

Gupta R . Major depression: an illness with objective physical signs. World J Biol Psychiatry. 2009; 10(3):196-201. DOI: 10.1080/15622970902812072. View

19.

de Kloet E, Joels M, Holsboer F . Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005; 6(6):463-75. DOI: 10.1038/nrn1683. View

20.

Wang J, Derynck M, Nonaka D, Khodabakhsh D, Haqq C, Yamamoto K . Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci U S A. 2004; 101(44):15603-8. PMC: 524211. DOI: 10.1073/pnas.0407008101. View